Overview
Open Interventions → Pulmonary vasodilators. Choose Off, Low, Medium, High. Effect levels and flow targets represent illustrative modeled responses; they are not clinical dose instructions.
Treprostinil is a prostacyclin analogue that activates prostanoid receptors and promotes cAMP-mediated vasodilation. Extended-release oral treprostinil is distinct from the selective IP-receptor agonist selexipag and from infused treprostinil.
The paused reference covers the route (Oral extended-release maintenance tablets, taken with food after individualized titration.), example doses/settings, indications, adverse effects, contraindications/precautions and monitoring. These details are available after the intervention is selected.
What to monitor in the reference: Blood pressure, tolerability, interactions, hepatic function, symptoms, biomarkers and RV/haemodynamic response; review the local label before initiation or interruption.